Endothelial-to-mesenchymal transition (EndMT) is implicated in myofibroblast-like cell-mediated damage to coronary artery wall of Kawasaki disease (KD) patients, which subsequently increases the risk of coronary artery aneurysm. Many circular RNAs (circRNAs) have been reported to be associated with cardiovascular diseases. However, the roles and underlying molecular mechanism of circRNAs in KD-associated EndMT remains indefinite. In this research, we screened out circRNA-3302 from human umbilical vein endothelial cells (HUVECs) treated by sera from healthy controls (HCs) or KD patients via circRNA sequencing (circRNA-seq). In addition, circRNA-3302 upregulation was verified in endothelial cells stimulated by KD serum and pathological KD mice modeled with Candida albicans cell wall extracts (CAWS). Moreover, in vitro experiments demonstrated that overexpression of circRNA-3302 could markedly induce EndMT, and silencing of circRNA-3302 significantly alleviated KD serum-mediated EndMT. To further explore the molecular mechanisms of circRNA-3302 inducing EndMT, RNA sequencing (RNA-seq), a dual-luciferase reporter system, nuclear and extra-nuclear RNA isolation, RT-qPCR and Western blot analyses and so on, were utilized. Our data demonstrated that circRNA-3302 contributed to the KD-associated EndMT via sponging miR-135b-5p to enhance KIT expression. Collectively, our results imply that circRNA-3302 plays an important role in KD-associated EndMT, providing new insights into minimizing the risks of developing coronary artery aneurysms.
The nanorod-structured (Au−Pd)/CeO 2 catalysts with different Au/Pd ratios were prepared from Al−Ce−Au−Pd precursor alloys through combined dealloying and calcination treatment. XRD, SEM, TEM, XPS, Raman spectroscopy, and N 2 adsorption−desorption measurements were applied to test the structure and physicochemical properties of samples. Catalytic evaluation results imply that the (Pd 0.15 −Au 0.15 )/CeO 2 catalyst calcined at 500 °C possesses optimal catalytic activity for CO oxidation when compared with other catalysts with different Au/ Pd ratios or (Pd 0.15 -Au 0.15 )/CeO 2 calcined at other temperatures, whose 50% and 99% reaction temperature can be reached as low as 50 and 85 °C, respectively. This superior catalytic property is attributed to their robust nanorod structure and the introduction of noble bimetal Pd and Au, which can construct a nanoscale interface to access fast electron motion, thus enhancing catalytic efficiency.
Supported Pt-based catalysts have been identified as highly selective catalysts for CO oxidation, but their potential for applications has been hampered by the high cost and scarcity of Pt metals as well as aggregation problems at relatively high temperatures. In this work, nanorod structured (TiO2−Pt)/CeO2 catalysts with the addition of 0.3 at% Pt and different atomic ratios of Ti were prepared through a combined dealloying and calcination method. XRD, XPS, SEM, TEM, and STEM measurements were used to confirm the phase composition, surface morphology, and structure of synthesized samples. After calcination treatment, Pt nanoparticles were semi-inlayed on the surface of the CeO2 nanorod, and TiO2 was highly dispersed into the catalyst system, resulting in the formation of (TiO2−Pt)/CeO2 with high specific surface area and large pore volume. The unique structure can provide more reaction path and active sites for catalytic CO oxidation, thus contributing to the generation of catalysts with high catalytic activity. The outstanding catalytic performance is ascribed to the stable structure and proper TiO2 doping as well as the combined effect of Pt, TiO2, and CeO2. The research results are of importance for further development of high catalytic performance nanoporous catalytic materials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.